1.
Hong HC-H, Gooderham M, Kwatra S, Gregoriou S, Yosipovitch G, Biswas P, Selfridge A, Koulias C, Güler E. Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials. J of Skin [Internet]. 2024Mar.18 [cited 2024Sep.20];8(2):s380. Available from: https://dermsquared.com/skin/article/view/2691